netFormulary Central Lancashire Formulary NHS
Lancashire Teaching Hospitals NHS Foundation Trust
Chorley and South Ribble CCG
Greater Preston CCG
 
 Search
 Formulary Chapter 12: Ear, nose and oropharynx - Full Chapter
12.01  Drugs acting on the ear
12.01.01  Otitis externa
12.01.01  Astringent preparations
12.01.01  Anti-inflammatory preparations
Betamethasone ear drops
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Dexamethasone with Antibacterial (Otomize®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Dexamethasone with Antibacterials (ear) (Sofradex®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Flumetasone 0.02% with Clioquinol 1% (Locorten-Vioform®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Hydrocortisone Acetate 1% with Gentamicin 0.3% (Gentisone® HC)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
12.01.01  Anti-infective preparations to top
Ciprofloxacin 0.3%
(ear drops)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

(unlicensed use of eye drops)

 
   
12.01.01  Other aural preparations
12.01.02  Otitis media
12.01.03  Removal of ear wax
Olive Oil Ear Drops
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Purple

in a suitable container

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

 
   
Sodium Bicarbonate
(ear drops)
 Track Changes
Formulary
Purple

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

 
   
12.02  Drugs acting on the nose
12.02.01  Drugs used in nasal allergy to top
12.02.01  Antihistamines
Azelastine Hydrochloride (Rhinolast®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
12.02.01  Corticosteroids
Beclometasone Dipropionate nasal spray (Beconase®)
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Purple

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 
Fluticasone Propionate nasal spray
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green
 
   
Mometasone Furoate nasal spray (Nasonex®)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green
 
   
Betamethasone nasal drops
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Amber
 
   
Fluticasone Propionate (Flixonase Nasule®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

for nasal polyps

 
   
12.02.01  Cromoglicate
12.02.02  Topical nasal decongestants
Sodium chloride 0.9% nasal drops
View adult BNF View SPC online View SMC online View childrens BNF  Track Changes
First Choice
Purple

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE in primary care.

 
Glucose 25% in glycerin nose drops
View adult BNF View SPC online View SMC online View childrens BNF  Track Changes
Formulary
Red

special from preston pharmaceuticals

 
   
Sodium chloride 0.9% nasal spray
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

For Post-operative use ONLY

Supply from Inpatient pharmacy only

 
   
12.02.02  Sympathomimetics to top
Ephedrine nasal drops
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Purple

Drug included in CCG low priority prescribing policy. DO NOT PRESCRIBE IN PRIMARY CARE.

 
   
Xylometazoline (Otrivine®)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Purple

Drug included within CCG low priority prescribing policy. DO NOT PRESCRIBE IN primary care.

 
   
12.02.02  Antimuscarinic
Ipratropium Bromide (Rinatec®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
12.02.03  Nasal preparations for infection
12.02.03  Nasal Staphylococci
Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% (Naseptin®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Mupirocin 2% (Bactroban Nasal®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
12.03  Drugs acting on the oropharynx
12.03.01  Drugs for oral ulceration and inflammation to top
Benzydamine (Difflam®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Purple

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 
   
Choline Salicylate (Bonjela® Adult)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Purple

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 
   
Hydrocortisone (Corlan®)
(mouth ulcers)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Betamethasone 500mcg tablets
(mouth ulcers)
View adult BNF View SPC online View childrens BNF  Track Changes
Unlicensed Drug Unlicensed
Red

Dissolve in 20ml water and rinse around the mouth 4 times daily; not to be swallowed.

 
   
12.03.02  Oropharyngeal anti-infective drugs
12.03.02  Oropharyngeal Fungal infections
Miconazole (Daktarin®)
(oromucosal gel sugar-free)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Purple

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 
   
Nystatin oral suspension (Nystan®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
12.03.02  Oropharyngeal Viral infections
12.03.03  Lozenges and sprays
12.03.04  Mouthwashes, gargles, and dentifrices to top
Chlorhexidine mouthwash
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Purple

Drug included within CCG low priority prescribing policy. EXEMPTIONS EXIST FOR CERTAIN INDICATIONS. Please consult attached policy for list of excepted indications for prescribing of this drug.

 
   
Mouthwash solution tablets
View adult BNF View SPC online View SMC online View childrens BNF  Track Changes
Formulary
Red

Hospital inpatients only

 
   
12.03.05  Treatment of dry mouth
12.03.05  Local Treatment
Artificial saliva spray (Salivese®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Biotene Oralbalance®
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Salivix® pastilles
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Gelclair sachets
View adult BNF View SPC online View SMC online View childrens BNF  Track Changes
Formulary
Amber

Palliative care advice only

 
   
Glycerin and lemon swabs
View adult BNF View SPC online View SMC online View childrens BNF  Track Changes
Formulary
Red

For hospital inpatients only

 
   
12.03.05  Systemic treatment
pilocarpine Hydrochloride (Salagen®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Suitable for prescribing in primary care following recommendation or initiation by a specialist. Little or no specific monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Brief prescribing document or information sheet may be required.  

Amber 1

Suitable for prescribing in primary care following recommendation or initiation by a specialist. Minimal monitoring required. Patient may need a regular review, but this would not exceed that required for other medicines routinely prescribed in primary care. Full prior agreement about patient’s on-going care must be reached under the shared care agreement.  

Amber 2

Initiated by specialist and transferred to primary care following a successful initiation period. Significant monitoring required on an on-going basis. Full prior agreement about patient’s on-going care must be reached under the shared care agreement. Suitable for enhanced service.  

Black

NOT recommended for use by the NHS in Lancashire. Includes medicines that NICE has not recommended for use and terminated technology appraisals, unless there is a local need.  

Blue

Products shown as blue have different Traffic Light List classifications dependent on indication. See the accompanying text next to the product for further information  

Green

Appropriate for initiation and ongoing prescribing in both primary and secondary care. Generally, little or no routine drug monitoring is required.  

Purple

Low Priority for Prescribing - see Low Priority for Prescribing Policy  

Red

Medicine is supplied by the hospital for the duration of the treatment course. Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.  

Red Specialist Centre

Prescribing restricted to Specialist Centres only  

netFormulary